TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Option, Credit Risk, Gains (Losses) on Assets
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Fair Value, Option, Credit Risk, Gains (Losses) on Assets of $0 for the 12-month period ending 2014-12-31, per its 20-F filed 2015-02-09.
Discontinued › Income Statement › Other Income
us-gaap:FairValueOptionCreditRiskGainsLossesOnAssets · last filed 2015-02-09
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, option, credit risk, gains (losses) on assets for the quarter ending 2013-03-31 was $3.00M, a 76.92% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, option, credit risk, gains (losses) on assets for the quarter ending 2012-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, option, credit risk, gains (losses) on assets for the quarter ending 2012-03-31 was $13.00M, a 94.25% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, option, credit risk, gains (losses) on assets for the quarter ending 2011-12-31 was -$159.00M.
| Period end | Fair Value, Option, Credit Risk, Gains (Losses) on Assets 3 month | Fair Value, Option, Credit Risk, Gains (Losses) on Assets 6 month | Fair Value, Option, Credit Risk, Gains (Losses) on Assets 9 month | Fair Value, Option, Credit Risk, Gains (Losses) on Assets 12 month | Fair Value, Option, Credit Risk, Gains (Losses) on Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 20-F · filed 2015-02-09 | ||||
| 2013-12-31 | $2.00M 20-F · filed 2015-02-09 | ||||
| 2013-03-31 | $3.00M 6-K · filed 2013-05-02 | ||||
| 2012-12-31 | $5.00M 6-K · filed 2013-05-02 | ||||
| 2012-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2012-08-02 | $13.00M 6-K · filed 2012-08-02 | -$146.00M derived: sum of 3 quarters · filed 2014-02-10 | -$156.00M derived: sum of 4 quarters · filed 2014-02-10 | |
| 2012-03-31 | $13.00M 6-K · filed 2012-05-09 | -$146.00M derived: sum of 2 quarters · filed 2014-02-10 | -$156.00M derived: sum of 3 quarters · filed 2014-02-10 | -$208.00M derived: sum of 4 quarters · filed 2014-02-10 | |
| 2011-12-31 | -$159.00M derived: 20-F 12 month − 6-K 9 month · filed 2014-02-10 | -$169.00M derived: sum of 2 quarters · filed 2014-02-10 | -$221.00M derived: sum of 3 quarters · filed 2014-02-10 | $5.00M 20-F · filed 2014-02-10 | $164.00M 20-F · filed 2012-02-17 |
| 2011-09-30 | -$10.00M derived: 6-K 9 month − 6-K 6 month · filed 2011-11-02 | -$62.00M derived: sum of 2 quarters · filed 2011-11-02 | $164.00M 6-K · filed 2011-11-02 | $35.00M derived: sum of 4 quarters · filed 2013-02-12 | |
| 2011-06-30 | -$52.00M derived: 6-K 6 month − 6-K 3 month · filed 2011-07-28 | $174.00M 6-K · filed 2011-07-28 | $45.00M derived: sum of 3 quarters · filed 2013-02-12 | ||
| 2011-03-31 | $226.00M 6-K · filed 2011-05-11 | $97.00M derived: sum of 2 quarters · filed 2013-02-12 | |||
| 2010-12-31 | -$129.00M derived: 20-F 12 month − 6-K 9 month · filed 2013-02-12 | $164.00M 20-F · filed 2013-02-12 | $266.00M 20-F · filed 2011-02-15 | ||
| 2010-09-30 | $293.00M 6-K · filed 2010-11-02 | ||||
| 2010-03-31 | $266.00M 6-K · filed 2011-05-11 | ||||
| 2009-12-31 | $293.00M 20-F · filed 2011-02-15 |